The results demonstrated that BBR treatment could inhibit the development of CRC, evidenced by the decreased weight loss, reduced number of polyps, better pathological morphology, and decreased the expression of Ki-67 compared with AOM/DSS group. Here, MKI67 is linked to colorectal carcinoma.